World’s biggest multibillionaire investor is buying THIS by the ton [picture]

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Edward J. Schutter net worth and biography

Edward Schutter Biography and Net Worth

Director of Establishment Labs

Ed Schutter has over thirty years of pharmaceutical industry experience and is currently CEO of Arbor Pharmaceuticals. Ed was previously President of Sciele (Shionogi) Pharmaceuticals prior to joining Arbor. Prior to Sciele, Ed served as VP of Global Business development at Solvay Pharmaceuticals based in Basel, Switzerland. He also held several senior management roles at the U.S. subsidiary of Solvay during his twenty years with the organization. He began his pharmaceutical career with Reid-Provident Labs, a small entrepreneurial pharmaceutical company based in Atlanta, GA. Ed is a registered pharmacist with a BS in Pharmaceutical Sciences from Mercer University, an MBA from Kennesaw State University and has completed graduate studies in International Business at Njienrode University, Amsterdam, Netherlands. He is currently a board member of Arbor, Vitruvias Therapeutics, Terrascend (TER.CN) and Establishment Labs (ESTA, NASDQ) and has been a previous board member of Knight Therapeutics (GUD.TO), Mercer University Board of Trustees, American Diabetes Association, American Heart Association as well as several other private pharma companies and nonprofit organizations.

How do I contact Edward J. Schutter?: The corporate mailing address for Mr. Schutter and other Establishment Labs executives is Building B15 and 25 Coyol Free Zone, Alajuela G2, . Establishment Labs can also be reached via phone at (062) 434-2400 and via email at [email protected]. Learn More on Edward J. Schutter's contact information.
Has Edward J. Schutter been buying or selling shares of Establishment Labs?: Edward J. Schutter has not been actively trading shares of Establishment Labs during the past quarter. Most recently, on Tuesday, November 23rd, Edward J. Schutter bought 2,467 shares of Establishment Labs stock. The stock was acquired at an average cost of $62.50 per share, with a total value of $154,187.50. Learn More on Edward J. Schutter's trading history.
Who are Establishment Labs' active insiders?: Establishment Labs' insider roster includes Juan Chacon-Quiros (Founder), Dennis Condon (Director), Roberto de Mezerville (CTO), Renee Gaeta (CFO), Lisa Gersh (Director), Nicholas Lewin (Director), and Edward Schutter (Director). Learn More on Establishment Labs' active insiders.
Are insiders buying or selling shares of Establishment Labs?: During the last twelve months, Establishment Labs insiders bought shares 3 times. They purchased a total of 9,250 shares worth more than $214,052.50. The most recent insider tranaction occured on December, 14th when Director Nicholas Sheridan Lewin bought 2,000 shares worth more than $54,080.00. Insiders at Establishment Labs own 11.4% of the company. Learn More about insider trades at Establishment Labs.
Information on this page was last updated on 12/14/2023.

Edward J. Schutter Insider Trading History at Establishment Labs

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/23/2021	Buy	2,467	$62.50	$154,187.50
11/17/2021	Buy	2,560	$69.00	$176,640.00

Edward J. Schutter Buying and Selling Activity at Establishment Labs

Establishment Labs Company Overview

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Today's Range

Now: $48.54

$45.98

$48.95

50 Day Range

MA: $47.78

$35.80

$55.38

2 Week Range

Now: $48.54

$16.96

$73.00

Volume

212,618 shs

Average Volume

424,553 shs

Market Capitalization

$1.33 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.24